Nutex Health, INC 10-K annual reports

Nutex Health Inc. reported significant revenue and net income growth in 2025, driven by its hospital division and successful navigation of the No Surprises Act's arbitration process, despite facing ongoing litigation and regulatory uncertainties.

Nutex Health Inc. reported a significant financial turnaround in 2024 with a net income of $52.1 million, driven by a 93.8% revenue increase to $479.9 million, despite restating prior financials and identifying additional material weaknesses in internal controls.

Nutex Health files an amendment to its annual report to include previously omitted information regarding directors, executive officers, corporate governance, executive compensation, security ownership, related person transactions, and principal accountant fees.

Nutex Health's 2024 10-K filing highlights strategic growth, regulatory navigation, and financial performance amid evolving healthcare dynamics.

Nutex Health has filed an amendment to its annual report to include previously omitted information regarding directors, executive compensation, and related matters.

Nutex Health Inc. has issued a convertible promissory note and warrants to an unnamed holder, outlining terms for repayment, interest, and potential conversion to common stock.